Sotera Health CompanySHCNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 92% recommend buying.

Consensus Rating

Buy

12 analysts·Moderate coverage

92%

Rating Distribution

Strong Buy

00%

Buy

1192%

Hold

18%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 28% higher.

Bear Case

$20.00

+13%

Consensus

$22.67

+28%

Bull Case

$24.00

+35%

Price Range12 analysts

Low

Consensus

High

$20.00

$24.00

Current Target

Current Price

$17.76

Upside to Target

$4.91

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.94(5 analysts)

P/E91x

Current: 90.5x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+6.01%

EPS+10.93%

FY2028

Rev+7.05%

EPS+15.31%

Earnings Surprises

Beat rate:50%(6/12 quarters)

Avg surprise:+5.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 9, 2026Piper Sandler

Sotera Health upgraded to Overweight from Neutral at Piper Sandler

Target:$24.00

+27.6%from $18.81

Jan 8, 2026RBC Capital

RBC Capital Starts Sotera Health (SHC) at Outperform

Target:$24.00

+27.6%from $18.81

Nov 5, 2025Piper Sandler

Sotera Health price target raised to $17 from $15 at Piper Sandler

Target:$17.00

+5.3%from $16.15

Nov 5, 2025Barclays

Sotera Health price target raised to $20 from $19 at Barclays

Target:$20.00

+21.7%from $16.43

Oct 2, 2025Barclays

Sotera Health price target raised to $19 from $17 at Barclays

Target:$19.00

+17.4%from $16.19

May 5, 2025Goldman Sachs

Sotera Health upgraded to Buy from Neutral at Goldman Sachs

Target:$17.00

+31.6%from $12.92

Dec 5, 2024Jefferies

Sotera Health (SHC) PT Lowered to $15 at Jefferies

Target:$15.00

+15.6%from $12.98

Nov 6, 2024Jefferies

Sotera Health (SHC) PT Raised to $18 at Jefferies

Target:$18.00

+17.9%from $15.27

Aug 6, 2024Barclays

Sotera Health price target raised to $17 from $14 at Barclays

Target:$17.00

+19.5%from $14.22

Jun 6, 2024Jefferies

Sotera Health (SHC) PT Raised to $14.50 at Jefferies

Target:$14.50

+21.0%from $11.98

May 21, 2024Piper Sandler

Piper Sandler Starts Sotera Health (SHC) at Neutral

Target:$13.00

+19.2%from $10.91

May 3, 2024RBC Capital

Sotera Health (SHC) PT Lowered to $17 at RBC Capital

Target:$17.00

+55.8%from $10.91

Apr 10, 2024Barclays

Sotera Health price target lowered to $14 from $19 at Barclays

Target:$14.00

+20.5%from $11.62

Mar 25, 2024Jefferies

Jefferies Upgrades Sotera Health (SHC) to Buy

Target:$15.50

+29.9%from $11.94

Jun 26, 2023Loop Capital Markets

Analyst Upgrades Sotera Health Shares To Overweight, Cites Strong Revenue Growth Outlook

Target:$24.00

+29.1%from $18.59

Jan 10, 2023Wolfe Research

Sotera Health upgraded to Outperform from Peer Perform at Wolfe Research

Target:$25.00

+44.9%from $17.25

Jan 10, 2023Barclays

Barclays Upgrades Sotera Health (SHC) to Overweight

Target:$22.00

+27.5%from $17.25

Nov 23, 2022Goldman Sachs

Goldman Sachs Maintains Neutral on Sotera Health, Lowers Price Target to $8

Target:$8.00

-1.4%from $8.12

Nov 15, 2022Barclays

Barclays Downgrades Sotera Health to Underweight, Lowers Price Target to $6

Target:$6.00

-15.9%from $7.13

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance